Funder: American Association for Cancer Research
Due Dates (Anticipated): May 2026 (Letter of Intent) | August 2026 (Full application, by invitation)
Funding Amounts: $450,000 total over 3 years; typically one award per cycle
Summary: Supports early-career, innovative research projects focused on triple negative breast cancer with the potential for transformative impact.
Key Information: Applicants must be early-career, tenure-eligible assistant professors and AACR members; only triple negative breast cancer projects are eligible.